Cybersecurity as a Competitive Edge in MedTech

Key Takeaways

• Cybersecurity is now a mandatory requirement for medical devices.
• Investors increasingly scrutinize cybersecurity measures thoroughly.
• Proactive cybersecurity prevents costly delays and regulatory issues.
• Design cybersecurity into products from the initial stages.
• Simplify cybersecurity communication, avoiding technical jargon.
• Cybersecurity is a strategic differentiator in MedTech.

Table of Contents

• Key Takeaways
• Unlocking the Power of Cybersecurity for Medical Device Innovators
• The Cybersecurity Mandate: From Optional to Mandatory
• Cybersecurity from an Investor’s Perspective
• Defining a “Cyber Device”
• Cybersecurity and the Marketing Perspective
• Designing for Cybersecurity: An Iterative Process
• Overcoming the Cybersecurity Jargon Barrier
• Cybersecurity as a Competitive Advantage

Why this matters

The stakes for medical device cybersecurity have never been higher. Patient safety and organizational trust hinge on the integrity of connected medical devices. Failures can lead to dire consequences, including patient harm, data breaches, and significant financial and reputational damage for manufacturers. The FDA's Cybersecurity in Medical Devices Final Guidance, dated February 3, 2026, mandates proactive cybersecurity measures throughout the device lifecycle, transforming it from a mere compliance checkpoint into a strategic necessity. This guidance, alongside evolving standards like IEC 81001-5-1, ISO 14971, and AAMI TIR57, underscores the critical need for integrating security from the ground up. Investors and healthcare providers increasingly scrutinize cybersecurity posture as a key indicator of product viability and manufacturer reliability. Devices lacking adequate security risk market exclusion and regulatory delays. Conversely, devices engineered with security by design gain a distinct market advantage, demonstrating a commitment to safety and regulatory adherence. Embracing cybersecurity as a fundamental aspect of product development is essential for accelerating market adoption and ensuring sustained success in the MedTech landscape.

Unlocking the Power of Cybersecurity for Medical Device Innovators

In the rapidly evolving world of medical technology, cybersecurity has emerged as a critical factor that can make or break a company’s success. Once seen as a mere regulatory hurdle, cybersecurity is now a strategic imperative that savvy MedTech innovators are leveraging to gain a competitive edge. In this in-depth exploration, we dive into a panel discussion from the LSI Europe 2025 conference, where industry experts share their insights on transforming cybersecurity from a challenge into a differentiator.

The Cybersecurity Mandate: From Optional to Mandatory

Cybersecurity is no longer a nice-to-have for medical device manufacturers - it’s a non-negotiable requirement. As Christian Espinosa, CEO and Founder of Blue Goat Cyber, explains, “Cybersecurity is no longer optional. It’s a requirement, and many MedTech innovators are still learning the hard way that it’s now a requirement. It’s no longer optional, and it can be a deal killer.”

The stakes are high, as cybersecurity breaches can have devastating consequences for patient safety. Espinosa cites real-world examples, such as the ability to hack into surgical robots, drug infusion pumps, pacemakers, and defibrillators - potentially causing paralysis, overdoses, or even death. These risks have caught the attention of regulators, healthcare providers, and investors alike, making cybersecurity a critical consideration for any medical device seeking market approval and adoption.

Cybersecurity from an Investor’s Perspective

Sean Lavin, MD, an investor at Alpha Lavin Advisors, shares his insights on how the investment community is approaching cybersecurity in the MedTech space. “I think, honestly, it is slowly becoming a concern, and if two years ago it was 5% of companies that thought about it in the startup world, it’s probably 15 or 20% now, but it’s still a long way from everybody looking at it.”

Lavin highlights three common ways companies learn about the importance of cybersecurity: through educational sessions like this one, when the FDA pushes back on their lack of cybersecurity measures, or when a hospital or healthcare system rejects their device due to insufficient security. He emphasizes the importance of reverse-engineering the cybersecurity requirements based on the end-user’s needs, rather than waiting until the last minute to address it.

“I think companies learn about it in one of three ways. They either, you know, meet a company like this or come to a session like this and learn this way, or they find out when the FDA pushes back on something they didn’t do, which is not a great way to do it they or they even later stage if they got through the FDA a while ago. They go to sell a product to a hospital or hospital system, and say you don’t meet our requirements or you need to make a change. The latter two are I believe I don’t know more expensive but certainly take a lot longer and interrupt plans quite a bit more than than if you do it early.”

Defining a “Cyber Device”

One of the key challenges in the MedTech industry is understanding what constitutes a “ cyber device” - a term that has significant implications for regulatory compliance and patient safety. Espinosa provides a clear definition: “A cyber device is to make it very simple. It has software, and there’s some sort of interface. The confusing part comes into the interface. Even if it has a USB port, that is considered an interface that could be used to connect to the internet because I could easily plug a wireless adapter into that USB port.”

This broad definition means that even seemingly innocuous medical devices with basic connectivity features can be considered “cyber devices” and must be designed with robust cybersecurity measures in place. Failing to do so can lead to costly delays, regulatory hurdles, and potentially catastrophic patient safety risks.

Cybersecurity and the Marketing Perspective

Claudia Holy, Co-Managing Director of Podymos, a MedTech marketing agency, emphasizes the importance of understanding the end-user’s perspective and concerns when it comes to cybersecurity. “It’s really about understanding what is important to the end user and who the end users are who care about cybersecurity. So is it the investors, is it the hospitals, and actually what questions are they asking, because that’s then how we, you know, reverse engineer it to make sure that we’re actually matching those claims as we go forward.”

Holy also highlights the need to simplify the cybersecurity messaging, as the industry is rife with jargon and technical terminology that can alienate key stakeholders. “Whenever you use jargon as well, you really isolate your market or you shrink your market down because only a certain number of the audience will understand that. So it’s How do we make it specific and action and understandable by all?”

• Reverse-engineer your cybersecurity messaging to address the specific concerns and questions of your target audience, whether that’s investors, healthcare providers, or patients.
• Simplify your language and avoid industry jargon to ensure your cybersecurity claims are clear and accessible to all stakeholders.
• Leverage your sales team’s feedback to understand the real-world questions and objections you’ll need to address in your marketing and communications.

Designing for Cybersecurity: An Iterative Process

One of the key challenges in the MedTech industry is the tendency to treat cybersecurity as a one-time task, rather than an ongoing, iterative process. Espinosa emphasizes the importance of designing cybersecurity into the product from the very beginning, rather than trying to “bolt it on” at the end.

“Bolted on at the end becomes very costly. It causes delays. It frustrates investors. It makes the device less secure. So we’re trying to like part of my company’s mission is to raise the awareness that if you know you have a cyber device you could should be designing cyber security into your product versus trying to bolt it on at the end when your regulatory affairs person says what did you do about cyber security like oh we forgot about it and that seems to happen fairly often.”

Espinosa also highlights the need for continuous vigilance, as vulnerabilities and threats are constantly evolving. “Once a device is on the market, it could have a vulnerability profile like we’ve accepted these lowrisk vulnerabilities as acceptable risk to the patient. However, suppose someone develops a new exploit for that vulnerability and publishes it, allowing everyone to access it. In that case, it becomes relatively easy to exploit the vulnerability, thereby altering the risk profile. So it’s something that has to be continuously looked at.”

See also: Leveraging Market Intelligence and Cybersecurity to Drive, FDA IDE Cybersecurity Requirements: 2026 Submission Guide, and MQTT Vulnerabilities in Connected Medical Devices: FDA Risks, Controls, and Deficiency Patterns.

• Integrate cybersecurity into the product development lifecycle from the very beginning, rather than trying to bolt it on at the end.
• Adopt a secure software development lifecycle, such as the IEC 62304 standard, to ensure your software is designed with security in mind.
• Continuously monitor and address evolving cybersecurity threats and vulnerabilities, even after your device has been approved and launched.

Overcoming the Cybersecurity Jargon Barrier

One of the biggest challenges in the MedTech industry is the overwhelming amount of technical jargon and industry-specific terminology surrounding cybersecurity. Espinosa acknowledges this issue, noting that “in MedTech and in cyber combining MedTech and cybersecurity, we’ve got like the most jargon international standards possible. I mean, I heard someone do an interview yesterday, and literally, one sentence was all acronyms and ISO standards. There’s like no real word in there.”

Claudia Holy emphasizes the importance of simplifying the cybersecurity messaging to ensure it resonates with all stakeholders, not just the technical experts. “Whenever you use jargon as well, you really isolate your market, or you shrink your market down because only a certain number of the audience will understand that. So it’s How do we make it specific and action and understandable by all?”

By breaking down the complex technical details and focusing on the real-world implications and benefits of cybersecurity, MedTech innovators can effectively communicate the value proposition to a wider audience, including investors, healthcare providers, and patients.

• Avoid industry jargon and technical terminology when communicating about cybersecurity, and instead focus on the practical implications and benefits.
• Tailor your cybersecurity messaging to the specific needs and concerns of each stakeholder group, whether that’s investors, healthcare providers, or patients.
• Leverage storytelling and real-world examples to illustrate the importance of cybersecurity and its impact on patient safety and business outcomes.

Cybersecurity as a Competitive Advantage

While cybersecurity was once seen as a necessary evil, forward-thinking MedTech companies are now recognizing it as a strategic differentiator. By proactively addressing cybersecurity concerns and designing secure products, these innovators are gaining a competitive edge in the market.

As Sean Lavin points out, investors are increasingly scrutinizing a company’s cybersecurity readiness during the due diligence process. “I think, honestly, it is slowly becoming a concern, and if two years ago it was 5% of companies that thought about it in the startup world, it’s probably 15 or 20% now, but it’s still a long way from everybody looking at it.”

By demonstrating a robust cybersecurity strategy, MedTech companies can not only satisfy regulatory requirements but also appeal to healthcare providers and patients who are increasingly aware of the risks. This, in turn, can lead to faster market adoption, higher customer trust, and a stronger competitive position.

• Position your cybersecurity capabilities as a strategic advantage, rather than just a regulatory requirement.
• Highlight how your secure product design and ongoing monitoring can provide greater peace of mind for healthcare providers and patients.
• Leverage your cybersecurity readiness as a selling point to differentiate your offering from competitors in the eyes of investors and end-users.

Conclusion: Embracing Cybersecurity for MedTech Success

In the rapidly evolving world of medical technology, cybersecurity has emerged as a critical factor that can make or break a company’s success. By proactively addressing cybersecurity concerns, MedTech innovators can transform this challenge into a strategic advantage, gaining the trust of investors, healthcare providers, and patients alike.

As the panel discussion at LSI Europe 2025 has shown, the key to success lies in understanding the cybersecurity landscape, designing secure products from the ground up, and effectively communicating the value proposition to all stakeholders. By embracing this holistic approach, MedTech companies can unlock new opportunities, drive innovation, and ultimately improve patient outcomes - all while strengthening their competitive position in the market.

To learn more about how Blue Goat Cyber can help your MedTech company navigate the cybersecurity landscape, schedule a Discovery Session.

How Blue Goat approaches this

Our approach to medical device cybersecurity centers on tailored, proactive strategies designed to streamline regulatory compliance and enhance market readiness. We assist MedTech innovators in baking security into their products from initial design through postmarket support. Our team brings deep technical expertise, including Certified Information Systems Security Professionals (CISSP) and Offensive Security Certified Professionals (OSCP), with a background that includes experience in ex-military red teams. We provide clarity amidst complex requirements, translating technical jargon into actionable insights for engineers and leadership alike. Our methodology aligns with the latest FDA guidance, preparing your devices for successful review. Should the FDA raise cybersecurity deficiencies after our submission, we resolve them at no additional cost. We focus on practical, effective security measures that distinguish your products in a competitive market, ensuring they meet the stringent demands of healthcare providers and regulators. Learn more about our specialized support for FDA Premarket Cybersecurity Services.

FAQ

What is considered a 'cyber device' by the FDA?

A 'cyber device' is generally defined as any medical device that includes software and an interface. This interface could be a USB port or any other connection that allows external communication, potentially linking the device to networks or the internet.

How does cybersecurity impact medical device market approval?

The FDA mandates cybersecurity considerations for market approval. Devices lacking adequate cybersecurity measures may face delays in approval or rejection, particularly under the February 3, 2026 premarket cybersecurity guidance.

Why is cybersecurity important to MedTech investors?

MedTech investors view cybersecurity as an indicator of a company’s risk management and long-term viability. Devices with strong cybersecurity are less likely to incur costly breaches or regulatory non-compliance, protecting investment value.

When should cybersecurity be integrated into medical device development?

Cybersecurity should be integrated at the very beginning of the product development lifecycle. 'Bolting on' security measures later is significantly more expensive, causes delays, and can result in a less secure product.

Does the FDA prioritize cybersecurity for all medical devices?

The FDA prioritizes cybersecurity for all medical devices due to potential patient safety risks and the increasing interconnectivity of health systems. They emphasize a proactive approach to cybersecurity throughout the device lifecycle.

How can MedTech companies simplify cybersecurity communication?

Companies should avoid technical jargon and focus on real-world implications and benefits of their cybersecurity measures. Tailoring messages to specific audiences like investors, healthcare providers, or patients helps clarify complex topics.